CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 39 filers reported holding AGEX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$17,000
+88.9%
10,6450.0%0.00%
Q3 2020$9,000
-18.2%
10,6450.0%0.00%
Q2 2020$11,000
-78.8%
10,645
-80.6%
0.00%
Q1 2020$52,000
-48.0%
54,8630.0%0.00%
Q4 2019$100,000
-7.4%
54,8630.0%0.00%
Q3 2019$108,000
-46.5%
54,8630.0%0.00%
Q2 2019$202,000
+65.6%
54,863
+82.5%
0.00%
Q1 2019$122,000
+106.8%
30,068
+54.8%
0.00%
Q4 2018$59,00019,4230.00%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 2,997,156$4,646,0000.21%
Strategic Wealth Investment Group, LLC 65,187$101,0000.04%
Defender Capital, LLC. 34,897$54,0000.02%
Beirne Wealth Consulting Services, LLC 18,000$28,0000.02%
Prescott General Partners LLC 185,185$287,0000.01%
Summit X, LLC 20,500$32,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 244,770$379,0000.01%
Piscataqua Savings Bank 1,000$2,0000.00%
Sigma Planning Corp 51,700$80,0000.00%
Riggs Asset Managment Co. Inc. 1,160$2,0000.00%
View complete list of AGEX THERAPEUTICS INC shareholders